Related references
Note: Only part of the references are listed.Clinical Applications for microRNAs in Cancer
S. P. Nana-Sinkam et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2013)
Tumor-targeted Chlorotoxin-coupled Nanoparticles for Nucleic Acid Delivery to Glioblastoma Cells: A Promising System for Glioblastoma Treatment
Pedro M. Costa et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2013)
Synthetic miR-34a Mimics as a Novel Therapeutic Agent for Multiple Myeloma: In Vitro and In Vivo Evidence
Maria T. Di Martino et al.
CLINICAL CANCER RESEARCH (2012)
Tumor vasculature is a key determinant for the efficiency of nanoparticle-mediated siRNA delivery
L. Li et al.
GENE THERAPY (2012)
miR-34 – a microRNA replacement therapy is headed to the clinic
Andreas G. Bader
Frontiers in Genetics (2012)
MiR-34a Targeting of Notch Ligand Delta-Like 1 Impairs CD15+/CD133+ Tumor-Propagating Cells and Supports Neural Differentiation in Medulloblastoma
Pasqualino de Antonellis et al.
PLOS ONE (2011)
The miR-34 family in cancer and apoptosis
H. Hermeking
CELL DEATH AND DIFFERENTIATION (2010)
Oligonucleotide delivery in cancer therapy
Giuseppe De Rosa et al.
EXPERT OPINION ON DRUG DELIVERY (2010)
Postexposure protection of non-human primates against a lethal Ebola virus challenge with RNA interference: a proof-of-concept study
Thomas W. Geisbert et al.
LANCET (2010)
Nano and Microtechnologies for the Delivery of Oligonucleotides with Gene Silencing Properties
Giuseppe De Rosa et al.
MOLECULES (2009)
MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cells
C. Welch et al.
ONCOGENE (2007)
Differential regulation of microRNAs by p53 revealed by massively parallel Sequencing -: miR-34a is a p53 target that induces apoptosis and G1-arrest
Valery Tarasov et al.
CELL CYCLE (2007)
A microRNA component of the p53 tumour suppressor network
Lin He et al.
NATURE (2007)
Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis
Tsung-Cheng Chang et al.
MOLECULAR CELL (2007)
Transcriptional activation of miR-34a contributes to p53-mediated apoptosis
Nina Raver-Shapira et al.
MOLECULAR CELL (2007)
Building oligonucleotide therapeutics using non-natural chemistries
Charles Wilson et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2006)
Molecular events contributing to cell death in malignant human hematopoietic cells elicited by an IgG3-avidin fusion protein targeting the transferrin receptor
Patrick P. Ng et al.
BLOOD (2006)
RNAi-mediated gene silencing in non-human primates
TS Zimmermann et al.
NATURE (2006)
Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs
DV Morrissey et al.
NATURE BIOTECHNOLOGY (2005)
Efficient encapsulation of antisense oligonucleotides in lipid vesicles using ionizable aminolipids: formation of novel small multilamellar vesicle structures
SC Semple et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2001)
Share Paper
